4Henderson J, Dunnett M, et al. Targeting the subthalamic nucleus in the treatment of Parkinson ' s disease. Brain Research Bulletin, 1998 , 46 ( 6 ) : 467 -474.
5Woods SP, Fields JA, TrYster A1, et al. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson' s disease: a critical review. Neuropsychol Rev, 2002, 12(2): 111-126.
6Parsons TD, Rogers SA, Braaten AJ, et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson ' s disease : a meta-analysis. Lancet Neurol, 2006, 5(7): 578-588.
7Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol, 2008, 7(7) : 605-614.
8York MK, Wilde EA, Simpson R. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci, 2009, 287(1-2) : 159- 171.
9Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN- DBS in Parkinson disease. Neurology, 2009, 72 ( 1 ) : 42-49.
10York MK, Dulay M, Macias A, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson' s disease. J Neurol Neurosurg Psychiatry, 2008, 79(7): 789-795.
